U.S. Transportation Stock News

Global Ship Lease (GSL) has expanded its newbuilding program with five additional mid-size, ultra-high-reefer, wide-beam containerships, a US$413 million commitment that extends contracted revenue visibility well into the next decade. See our latest analysis for Global Ship Lease. At a share price of US$38.11, Global Ship Lease has seen its share price return advance 9.1% year to date, while the 1 year total shareholder return of 52.6% and 3 year total shareholder return above 2x highlight...

Recently, Missouri American Water, a subsidiary of American Water Works, requested approval from the Missouri Public Service Commission for new water and wastewater rates to fund about US$1.60 billion of infrastructure upgrades planned between June 2025 and May 2028, potentially affecting average residential bills from June 2027. This sizable rate case highlights how American Water Works seeks to recover extensive investment in system modernization, water quality improvements, and service...

Axsome Therapeutics, Inc. recently reported dosing the first patient in its FOCUS-3 Phase 3 trial of solriamfetol for adolescents with ADHD, while also being added to multiple Russell large-cap and growth indices and removed from several small-cap indices. This combination of a pivotal late-stage CNS trial in a new age group and a shift into larger-cap equity benchmarks may influence how investors think about Axsome’s clinical profile and market positioning. We’ll now examine how the Phase 3...

Mirum Pharmaceuticals recently reported past positive pivotal phase II results from the PROGRESS study of zilurgisertib in fibrodysplasia ossificans progressiva and secured US FDA priority review acceptance for its new drug application, with a decision scheduled for late September 2026. This combination of encouraging data in an ultra-rare indication and accelerated regulatory review could meaningfully broaden Mirum’s rare disease portfolio beyond its existing commercial assets. We’ll now...

Regencell Bioscience Holdings (RGC) is back in focus after disclosing cooperation with a U.S. Department of Justice investigation into trading in its shares, alongside mounting legal costs and going concern warnings. See our latest analysis for Regencell Bioscience Holdings. At a share price of $6.37, Regencell Bioscience Holdings has seen sharp selling pressure recently, with the 30 day share price return down 68.13% and the year to date share price return down 68.99%. The three year total...

In late June 2026, Vor Biopharma Inc. was added to a wide range of Russell indexes, including the Russell 2000, 2500, 3000, Microcap, and multiple related Growth and Value benchmarks. This broad inclusion significantly expands Vor Biopharma’s presence in benchmarked portfolios, potentially increasing its visibility among index-tracking and institutional investors. We’ll now examine how Vor Biopharma’s broad Russell index inclusion shapes the company’s investment narrative in light of recent...

American Tower (AMT) has just been added to several Russell value and defensive indices, drawing fresh attention to the stock as it posts a 1.53% session gain ahead of its July 28 earnings report. See our latest analysis for American Tower. Looking beyond the latest session, American Tower’s share price is down 14.47% over the past 30 days and 5.02% year to date, while the 1 year total shareholder return has declined 22.24%. This suggests momentum has been fading even as the new index...

In late June and early July 2026, CACI International announced that Dr. Dave Young became Executive Vice President and Chief Operating Officer and that returning leader Tom Kirkland was appointed Executive Vice President of Electronic Warfare, both joining the company’s executive leadership team. These appointments bring deep space, defense electronics, and battlefield technology experience into CACI’s top ranks, reinforcing its push toward mission-focused, technology-first national security...

In late June and early July 2026, Redwire Corporation’s subsidiary amended its credit agreement to lift revolving credit capacity from US$30.00 million to US$50.00 million while prepaying US$40.00 million of term loans, and separately secured a contract via Taiwan Color Optics Inc. to supply Penguin Mk2.5 VTOL uncrewed aerial systems to the Taiwan Coast Guard. Taken together, the new Taiwan Coast Guard UAS contract and the reshaped credit facilities highlight both operational demand for...

In the past quarter, MSC Industrial Direct Co., Inc. reported fiscal third-quarter 2026 sales of US$1,047.08 million and net income of US$80.36 million, with diluted EPS from continuing operations rising to US$1.44 from US$1.02 a year earlier, alongside margin expansion and productivity gains. Beyond the headline beat, the company’s sales force optimization, Mission Critical efficiency program, and raised free cash flow outlook underscored how operational improvements are feeding directly...

In recent days, CenterPoint Energy, Inc. in Houston reported that analysts now expect its Q2 2026 diluted EPS to be US$0.38, implying year-over-year growth of 31% ahead of the upcoming earnings release. Analysts also project CenterPoint Energy’s EPS for fiscal 2026 at US$1.91, suggesting that expectations for earnings expansion are becoming a central focus for investors ahead of the report. With analysts forecasting a 31% jump in quarterly EPS, we’ll now examine how this shapes CenterPoint...

Northwest Bancshares recently reported past first-quarter 2026 results that topped market expectations, with adjusted EPS of US$0.35 on revenue of US$175.06 million, and appointed Chad Ballard as Chief Information Officer effective May 18. This combination of earnings outperformance and a new technology leader highlights how operational execution and digital capabilities are becoming increasingly important for the bank’s business profile. Next, we’ll examine how the stronger-than-expected...

Amgen (AMGN) is back in focus after a federal judge blocked Colorado’s proposed 70% price cap on Enbrel, which removed an immediate regulatory threat to one of the company’s key revenue drivers. See our latest analysis for Amgen. The court decision has come on top of an already strong run in Amgen’s stock, with a 1-day share price return of 3.55% and a year to date share price return of 14.20%, while total shareholder return sits at 29.22% over one year and 87.63% over three years. This...

WesBanco (WSBC) has been removed from several Russell growth and small cap indexes, a change that can prompt mechanical buying and selling by index tracked funds and may influence short term trading volumes. See our latest analysis for WesBanco. Despite the recent index removals, WesBanco’s share price has been firm, with a 30 day share price return of 15.27% and an 18.90% share price return year to date. Over a longer horizon, the bank’s total shareholder return of 23.01% over one year and...

AI is reshaping expectations for interest rates, and that matters directly for financial sector stocks. Morgan Stanley now argues that AI driven gains could lift long term equilibrium rates, even as disinflationary effects get outweighed by stronger demand and investment. With markets paring back hopes for Federal Reserve cuts through 2026 and attention turning to upcoming FOMC meetings, investors are reassessing which large, financially strong companies might be better positioned if policy...

FirstEnergy Corp. previously announced it would release its second-quarter 2026 results after markets closed on July 28, followed by a July 29 analyst call and webcast detailing performance and updates on its operations. At the same time, the company has highlighted rising electricity demand from AI-driven data center expansion and its Energize365 grid investment program as key forces shaping its longer-term outlook. We’ll examine how growing AI-related data center power demand, and the...

Crane stock reaction to Russell index removal Crane (CR) came into focus after being removed from both the Russell 1000 Value-Defensive Index and the Russell 1000 Defensive Index, a change that can influence trading by index-tracking funds. See our latest analysis for Crane. The latest index changes come as Crane’s share price sits at $217.64, with a 30-day share price return of 15.24% and a 90-day share price return of 26.00%. Its 5-year total shareholder return of 273.34% reflects a strong...

Hecla Mining (HL) has been reshuffled into larger benchmarks, including the Russell 1000 and Russell Midcap indices, after removals from several Russell 2000 indices. This shift is drawing fresh attention to how the stock is currently valued. See our latest analysis for Hecla Mining. Recent index moves have coincided with a sharp pickup in Hecla Mining's share price momentum, with a 1 day share price return of 4.75% and a 30 day share price return of 10.49%. This sits against a 90 day share...

In late June and early July 2026, Arcturus Therapeutics announced a collaboration with Thermo Fisher Scientific, under which Thermo Fisher will supply integrated Phase 3 manufacturing, clinical research and potential commercial manufacturing services for ARCT-032, an investigational mRNA therapy for cystic fibrosis. This agreement aligns Thermo Fisher even more closely with cutting-edge mRNA and rare disease workflows, expanding its role as an end-to-end development and manufacturing...

Plug Power recently sold about US$39.2 million of federal investment tax credits tied to its St. Gabriel, Louisiana hydrogen liquefaction facility, a joint venture operated with Olin and considered one of North America’s largest hydrogen liquefaction plants. This move highlights how Olin’s participation in large-scale hydrogen infrastructure can unlock value from government incentives and broaden its role in the energy transition supply chain. We’ll now examine how monetizing tax credits at...

Keysight Technologies (KEYS) is in focus after announcing a joint GaN MMIC design workflow with WIN Semiconductors, connecting simulation, 3D layout, and evaluation board design in one environment for high frequency applications. See our latest analysis for Keysight Technologies. Despite a sharp 1 day share price decline of 6.48% and softer 7 day and 30 day share price returns, Keysight Technologies still shows stronger momentum over longer periods. The company has a 90 day share price return...

In recent days, Colgate-Palmolive advanced its long-range 2030 plan, emphasizing premium product offerings, tighter digital–physical retail integration, and routine stock-based compensation grants to non-employee directors under its Deferred Compensation Plan. This renewed focus on higher-value products and omnichannel execution, backed by the company’s entrenched brands and recurring consumer demand, has sharpened investor attention on the durability of its business model. We’ll now examine...

Structure Therapeutics recently reported positive Phase 2b trial results for its oral GLP-1 obesity drug aleniglipron, published in Nature Medicine, showing durable weight loss beyond 36 weeks and improved tolerability with a lower starting dose, while its Chief Scientific Officer exercised options and sold a portion of shares under a pre-arranged Rule 10b5-1 plan. Analysts at Cantor Fitzgerald and BMO Capital responded by reiterating positive views on aleniglipron’s potential as a leading...

Tesla, Inc. reported in early July that it produced 451,758 vehicles and delivered 480,126 in the second quarter of 2026, while its energy unit deployed 13.5 GWh of storage capacity. Yet despite this record operational performance, attention quickly shifted to the quality of demand and potential margin pressure from discounts and inventory drawdowns, underscoring how sentiment now hinges more on profitability and autonomy than raw delivery growth. We’ll now examine how Tesla’s record Q2...